Literature DB >> 18286166

Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis.

Daniel G Maluf1, Valeria R Mas, Kellie J Archer, Kenneth Yanek, Eric M Gibney, Anne L King, Adrian Cotterell, Robert A Fisher, Marc P Posner.   

Abstract

Loss of kidney graft function with tubular atrophy (TA) and interstitial fibrosis (IF) causes most kidney allograft losses. We aimed to identify the molecular pathways involved in IF/TA progression. Kidney biopsies from normal kidneys (n = 24), normal allografts (n = 6), and allografts with IF/TA (n = 17) were analyzed using high-density oligonucleotide microarray. Probe set level tests of hypotheses tests were conducted to identify genes with a significant trend in gene expression across the three groups using Jonckheere-Terpstra test for trend. Interaction networks and functional analysis were used. An unsupervised hierarchical clustering analysis showed that all the IF/TA samples were associated with high correlation. Gene ontology classified the differentially expressed genes as related to immune response, inflammation, and matrix deposition. Chemokines (CX), CX receptor (for example, CCL5 and CXCR4), interleukin, and interleukin receptor (for example, IL-8 and IL10RA) genes were overexpressed in IF/TA samples compared with normal allografts and normal kidneys. Genes involved in apoptosis (for example, CASP4 and CASP5) were importantly overexpressed in IF/TA. Genes related to angiogenesis (for example, ANGPTL3, ANGPT2, and VEGF) were downregulated in IF/TA. Genes related to matrix production-deposition were upregulated in IF/TA. A distinctive gene expression pattern was observed in IF/TA samples compared with normal allografts and normal kidneys. We were able to establish a trend in gene expression for genes involved in different pathways among the studied groups. The top-scored networks were related to immune response, inflammation, and cell-to-cell interaction, showing the importance of chronic inflammation in progressive graft deterioration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286166      PMCID: PMC2242778          DOI: 10.2119/2007-00111.Maluf

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Role of the microvascular endothelium in progressive renal disease.

Authors:  Duk-Hee Kang; John Kanellis; Christian Hugo; Luan Truong; Sharon Anderson; Dontscho Kerjaschki; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

Review 3.  Chronic rejection.

Authors:  P Libby; J S Pober
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

4.  Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.

Authors:  G R Bicknell; S T Williams; J A Shaw; J H Pringle; P N Furness; M L Nicholson
Journal:  Br J Surg       Date:  2000-11       Impact factor: 6.939

5.  Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').

Authors:  K Solez; R B Colvin; L C Racusen; B Sis; P F Halloran; P E Birk; P M Campbell; M Cascalho; A B Collins; A J Demetris; C B Drachenberg; I W Gibson; P C Grimm; M Haas; E Lerut; H Liapis; R B Mannon; P B Marcus; M Mengel; M J Mihatsch; B J Nankivell; V Nickeleit; J C Papadimitriou; J L Platt; P Randhawa; I Roberts; L Salinas-Madriga; D R Salomon; D Seron; M Sheaff; J J Weening
Journal:  Am J Transplant       Date:  2007-03       Impact factor: 8.086

6.  Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Authors:  D H Kang; S Anderson; Y G Kim; M Mazzalli; S Suga ; J A Jefferson; K L Gordon; T T Oyama; J Hughes; C Hugo; D Kerjaschki; G F Schreiner; R J Johnson
Journal:  Am J Kidney Dis       Date:  2001-03       Impact factor: 8.860

7.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

8.  Improved graft survival after renal transplantation in the United States, 1988 to 1996.

Authors:  S Hariharan; C P Johnson; B A Bresnahan; S E Taranto; M J McIntosh; D Stablein
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

9.  Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.

Authors:  V Mas; T Alvarellos; C Giraudo; P Massari; G De Boccardo
Journal:  Transplantation       Date:  2002-09-15       Impact factor: 4.939

10.  Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.

Authors:  M L Nicholson; J R Waller; G R Bicknell
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

View more
  25 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

2.  Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.

Authors:  Dany Anglicheau; Thangamani Muthukumar; Aurélie Hummel; Ruchuang Ding; Vijay K Sharma; Darshana Dadhania; Surya V Seshan; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2012-06-15       Impact factor: 4.939

Review 3.  Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics.

Authors:  Paul Perco; Rainer Oberbauer
Journal:  Semin Nephrol       Date:  2010-09       Impact factor: 5.299

4.  Discovery of SERPINA3 as a candidate urinary biomarker of lupus nephritis activity.

Authors:  Jessica L Turnier; Hermine I Brunner; Michael Bennett; Ashwaq Aleed; Gaurav Gulati; Wendy D Haffey; Sherry Thornton; Michael Wagner; Prasad Devarajan; David Witte; Kenneth D Greis; Bruce Aronow
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

5.  Fibrosis with inflammation at one year predicts transplant functional decline.

Authors:  Walter D Park; Matthew D Griffin; Lynn D Cornell; Fernando G Cosio; Mark D Stegall
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

Review 6.  Molecular pathways involved in loss of graft function in kidney transplant recipients.

Authors:  Valeria R Mas; Kellie J Archer; Mariano Scian; Daniel G Maluf
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

7.  Translational profiles of medullary myofibroblasts during kidney fibrosis.

Authors:  Ivica Grgic; A Michaela Krautzberger; Andreas Hofmeister; Matthew Lalli; Derek P DiRocco; Susanne V Fleig; Jing Liu; Jeremy S Duffield; Andrew P McMahon; Bruce Aronow; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

Review 8.  Deconvoluting the 'omics' for organ transplantation.

Authors:  Minnie M Sarwal
Journal:  Curr Opin Organ Transplant       Date:  2009-10       Impact factor: 2.640

Review 9.  Defining nephrotic syndrome from an integrative genomics perspective.

Authors:  Matthew G Sampson; Jeffrey B Hodgin; Matthias Kretzler
Journal:  Pediatr Nephrol       Date:  2014-06-03       Impact factor: 3.714

10.  Effects of CASP5 gene overexpression on angiogenesis of HMEC-1 cells.

Authors:  Haiyan Li; Yuzhen Li; Limin Cai; Bingxue Bai; Yanhua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.